Skin Laxity Clinical Trial
Official title:
An Open-Label, Single-Center, Single-Treatment, Safety and Effectiveness Evaluation of Percutaneous Radiofrequency in Achieving Submental Lift
NCT number | NCT02832674 |
Other study ID # | THERMI_0005 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 25, 2016 |
Est. completion date | April 8, 2017 |
Verified date | July 2016 |
Source | ThermiGen, LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A prospective evaluation of the ThermiRF device in treating skin laxity under the chin and
neck. Seventy male and female subjects between the age of 35 and 65 (inclusive) will be
enrolled in this trial. The first 30 subjects will have a total of 6 study visits while the
remainder will have a total of 5 study visits.
All subjects will have a single treatment administered. The first 30 subjects will have an
extra visit at Day 60 intended to allow collection of photo images post treatment to be used
for the validation of three blinded raters.
Photo images will be collected using 2D standard photography and 3D using the Vectra system.
The architecture of the skin in the affected area will be measured using the Cutometer, a
suction like instrument that measures elasticity. Sensory and safety will be measured using a
0-10 point numerical rating scale (NRS) and collection of safety reports. The study duration
is approximately 6 months.
Status | Completed |
Enrollment | 72 |
Est. completion date | April 8, 2017 |
Est. primary completion date | February 20, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Male or female between the age of 35 and 65 inclusive; - Mild to Moderate Skin Laxity Severity on the submental area defined as: "normal" muscle, "mild to moderate" skin laxity and "mild to moderate" fat; - Desire to improve jawline definitions and/or submental skin lift - Body mass index (BMI) =30; - Females of childbearing potential who are sexually active must be willing to use an approved method of birth control during study participation. - Cooperative, reliable, and able to read and comprehend English; - Able to read, understand, sign and date the informed consent document (English only); - Able and willing to comply with the schedule visit(s) and study requirements. Exclusion Criteria: - Excessive subcutaneous fat on the submental area - Use within 24 hours preceding surgery of ibuprofen, acetaminophen, any other analgesics, anti-inflammatory products, or any products including herbals and supplements that could interfere with the clinical assessments of this study (other than drugs used for anesthesia); - History of cosmetic treatments on the face and neck including but not limited to: facial skin tightening procedures within the past year, injectable fillers of any type, Botox on the lower face, ablative resurfacing laser treatment, none ablative, rejuvenative laser or light treatment within the past six months, deep facial peels, dermabrasion, face lift, neck lift, blepharoplasty or brow lift, contour threads or other. - History or current injury to the Head and Neck. - Severe solar elastosis - Clinically significant facial wounds, lesions or acute infections including cystic acne, dermatitis, lupus or other immunodeficiency affecting the dermis - Presence of metal stents or facial implants - Pregnant or planning pregnancy prior to the end of study participation - Current or past history of smoking - History or current diagnosis of cancer of any type - History of uncontrolled cardiovascular disease(i.e. myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other) - Known hypersensitivity to local anesthetic medications - History, or current bleeding disorders (i.e. hemophilia or von Willebrand disease), or anticipated treatment with prescription anticoagulants - Possesses a surgically implanted electronic device (i.e. pacemaker) - History of AIDs/HIV - Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years - Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurements - A family member of the investigator or an employee of the investigator. - Participation in any other investigational study within 30 days prior to consent; |
Country | Name | City | State |
---|---|---|---|
United States | New Jersey Plastic Surgery | Montclair | New Jersey |
Lead Sponsor | Collaborator |
---|---|
ThermiGen, LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tissue Lift at the Submental Area Measuring >/= 20 mm2 | A >/= 20 mm^2 change from baseline at Day 90 as measured quantitatively using 3D photo images (a calculation). | Change from baseline at Day 90 | |
Secondary | Percent of Participants Rated as Improved or Not Improved as Scored by the Blinded Rater/Reviewer | Overall improvement of submental lift was determined by a blinded rater panel using before and after photos | Change from baseline to Days 90 and 180 | |
Secondary | Physician Global Aesthetic Improvement Scale (P-GAIS) | A subjective assessment of overall improvement measured by the physician using the PGAIS where the physician rates the appearance of the treated area (submental area) with respect to lift compared to baseline photography at the defined time points. The 5-point scale measures from "Very much improved" to "worse". | Change from baseline at Days 90 and 180 | |
Secondary | Subject Global Aesthetic Improvement Scale (S-GAIS) | A subjective assessment of overall improvement measured by the participant using the SGAIS where the participant rates the appearance of the treated area (submental area) with respect to "lift"is measured from. the 5-point scale measures from Very much improved to worse. | Change from baseline at Days 90 and 180 | |
Secondary | Physician Global Satisfaction Questionnaire (P-GSQ) | A subjective assessment of global satisfaction as measured by the physician using the P-GSQ where the physician rates his/her level of satisfaction of the treatment and treated area based on 4 satisfaction questions respective to 1. changes to the treated area, 2. skin texture of the treated area, 3. satisfaction with treatment results and 4. likelihood to recommend the treatment as a treatment option. | Change from baseline at Days 90 and 180 | |
Secondary | Subject Global Satisfaction Questionnaire (S-GSQ) | A subjective assessment of global satisfaction as measured by the participant using the S-GSQ where the participant rates his/her level of satisfaction of the treatment and treated area based on 4 satisfaction questions respective to 1. changes to the treated area, 2. skin texture of the treated area, 3. satisfaction with treatment results and 4. likelihood to recommend the treatment as a treatment option. | Change from baseline at Days 90 and 180 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Completed |
NCT01713985 -
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
|
N/A | |
Completed |
NCT01971736 -
Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening
|
N/A | |
Completed |
NCT01708252 -
Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment
|
N/A | |
Completed |
NCT01713998 -
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
|
N/A | |
Completed |
NCT01708382 -
Feasibility Study: Lifting and Tightening of the Elbows
|
N/A | |
Completed |
NCT04296201 -
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
|
N/A | |
Completed |
NCT06000839 -
A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05929625 -
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
|
N/A | |
Terminated |
NCT01713569 -
Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
|
N/A | |
Completed |
NCT01519934 -
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
|
N/A | |
Completed |
NCT05605691 -
Post-Market Lower Eyelid Treatment With Renuvion in Greece
|
N/A | |
Completed |
NCT04477187 -
Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling
|
N/A | |
Completed |
NCT05590364 -
Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands
|
N/A | |
Active, not recruiting |
NCT06243744 -
Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery
|
N/A | |
Completed |
NCT04146584 -
Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
|
Phase 2 | |
Recruiting |
NCT05750901 -
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
|
N/A | |
Completed |
NCT04721600 -
Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance
|
N/A | |
Recruiting |
NCT06157567 -
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
|
N/A |